Recurrent adult immunoblastic lymphoma Clinical Trials

Delta Trials catalogs 6 clinical trials for Recurrent adult immunoblastic lymphoma in its publicly accessible dataset. Within this set, 0 currently recruiting participants and 5 trials have reached completion. This research occurs across 31 participating sites around the world. An additional 1 trial are in other active phases such as not yet recruiting or pending status. Since 2020, 1 trial were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.